Pierre Ferre has a diverse background in preclinical development and corporate operations, with experience at both Compugen and Pierre Fabre. With a Ph.D. in Physiopathology and a specialization in Immunology and Immunotherapy, Pierre has held various leadership positions within oncology programs. Their educational background includes degrees in Cell/Cellular and Molecular Biology, Pharmacokinetics, and Veterinary Medicine.
March 1, 2024 - present
April, 2021